UNSPSC 51284133: Cefodizime disodium

This classification denotes a beta-lactam antibacterial with the molecular formula C20H18N6O7S4.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HC1T51593A, chemically known as (z)-7-(2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido)-3-(5-carboxymethyl-4-methylthiazol-2-ylthiomethyl)-3-cephem-4-carboxylic acid, disodium salt, but more generally known as cefodizime disodium, which bears US NIH Compound Identifier 6321412.

European Medicines Agency schedules cefodizime disodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07401MIG. Most nations, for tariff purposes, schedule cefodizime disodium under HS 29419000. SMILES: CC1C(SC(N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4CSC(N4)N)SC2)C(=O)[O-])CC(=O)[O-].[NA+].[NA+].

UNSPSC 51284133 Cefodizime disodium is a Commodity code representing a specific injectable antibiotic pharmaceutical, but recent state and local procurement activity tagged under this code shows little alignment with the nominal product scope. The opportunities posted under this code span naloxone and drug deactivation systems (emergency response supplies), therapeutic pharmacy initiatives for direct-to-manufacturer prescription programs, medical and first aid supplies for fire rescue operations, and generic multi-source pharmaceuticals and OTC products through cooperative purchasing — none of which are cefodizime or injectable antibiotics specifically. The mismatch between the code's narrow pharmaceutical designation and the broad healthcare supply categories appearing in recent solicitations suggests either classification error in the state and local systems posting these opportunities or use of this code as a catchall for pharmaceutical-related procurements more broadly.

Activity appears across multiple issuing-body types, including county health departments (Seminole County, Florida), state health agencies (Texas HHS Commission), municipal fire departments (City of Tampa), and multi-state cooperative purchasing alliances (MMCAP). The most recent opportunities posted in 2026 include a Tampa Fire Department IFB for medical and first aid supplies (due March 13, 2026, estimated contract value $700,000, sheltered for certified Small Local Business Enterprises with a 5 percent bid discount), a Minnesota MMCAP RFP for generic multi-source pharmaceuticals and OTC products with responses due March 26, 2026, and a Texas HHS RFI on direct-to-manufacturer prescription programs (April 3, 2026). Geographic activity spans Florida, Texas, and Minnesota, with multi-state reach through cooperative purchasing arrangements. Because the recent opportunities do not represent cefodizime procurement, this code warrants close attention to whether reclassification or corrected tagging occurs before pursuing opportunities nominally listed under it.